US 11,702,424
Application 16/996,117 · Granted Jul 18, 2023
Bicyclic-fused heteroaryl or aryl compounds
Estimated expiration
April 3, 2035
8y 135d remaining
Earliest effective filing
Apr 3, 2015
+ 20 years
Apr 3, 2035
PTA +169d
Sep 19, 2035
TD cap (US 10,329,302)
Apr 3, 2035
Final
Apr 3, 2035
- Earliest effective filing
- Apr 3, 2015
- + 20 years
- Apr 3, 2035
- PTA +169d
- Sep 19, 2035
- TD cap (US 10,329,302)
- Apr 3, 2035
- Final
- Apr 3, 2035
This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included. Terminal disclaimers can affect PTA (In re Cellect, LLC).
Calculation details
Base term
- Filing date
- August 18, 2020
- Earliest effective filing
- April 3, 2015
- Issue date
- July 18, 2023
- PTA
- +169 days
- Base expiry (before PTA)
- April 3, 2035
April 3, 2015 + 20 years = April 3, 2035 + 169 PTA days = September 19, 2035
- Continuation of application 16/411,679, filed May 14, 2019, issued as US 10,793,579
- Continuation of application 15/862,691, filed Jan 5, 2018, issued as US 10,329,302
- Continuation of application 15/232,892, filed Aug 10, 2016, issued as US 9,879,022
- Continuation of application 14/678,114, filed Apr 3, 2015, issued as US 9,458,168
- Continuation of application 14/678,114, filed Apr 3, 2015, issued as US 9,458,168
- Continuation of application 15/232,892, filed Aug 10, 2016, issued as US 9,879,022
- Continuation of application 14/678,114, filed Apr 3, 2015, issued as US 9,458,168
- Continuation of application 15/862,691, filed Jan 5, 2018, issued as US 10,329,302
- Continuation of application 15/232,892, filed Aug 10, 2016, issued as US 9,879,022
- Continuation of application 14/678,114, filed Apr 3, 2015, issued as US 9,458,168
- PRO61/975,473 — Provisional — not used for base term
- PRO61/975,473 — Provisional — not used for base term
- PRO61/975,473 — Provisional — not used for base term
- PRO61/975,473 — Provisional — not used for base term
- PRO61/975,473 — Provisional — not used for base term
Terminal disclaimers
TD caps expiration to April 3, 2035 (earliest expiring referenced patent: US 10,329,302)
US 10,329,302· Application 15/862,691Capping patent
Bicyclic-fused heteroaryl or aryl compounds
- Filing date
- Jan 5, 2018
- Earliest effective filing
- Apr 3, 2015
- Issue date
- Jun 25, 2019
- PTA
- 0 days
- Calculated expiration
- Apr 3, 2035
Continuation of 15/232,892, filed Aug 10, 2016, issued as US 9,879,022
Continuation of 14/678,114, filed Apr 3, 2015, issued as US 9,458,168
Continuation of 14/678,114, filed Apr 3, 2015, issued as US 9,458,168
Apr 3, 2015 + 20y = Apr 3, 2035
US 9,879,022· Application 15/232,892
Bicyclic-fused heteroaryl or aryl compounds
- Filing date
- Aug 10, 2016
- Earliest effective filing
- Apr 3, 2015
- Issue date
- Jan 30, 2018
- PTA
- 0 days
- Calculated expiration
- Apr 3, 2035
Continuation of 14/678,114, filed Apr 3, 2015, issued as US 9,458,168
Apr 3, 2015 + 20y = Apr 3, 2035
US 10,793,579· Application 16/411,679
Bicyclic-fused heteroaryl or aryl compounds
- Filing date
- May 14, 2019
- Earliest effective filing
- Apr 3, 2015
- Issue date
- Oct 6, 2020
- PTA
- 0 days
- Calculated expiration
- Apr 3, 2035
Continuation of 15/862,691, filed Jan 5, 2018, issued as US 10,329,302
Continuation of 15/232,892, filed Aug 10, 2016, issued as US 9,879,022
Continuation of 14/678,114, filed Apr 3, 2015, issued as US 9,458,168
Continuation of 14/678,114, filed Apr 3, 2015, issued as US 9,458,168
Continuation of 15/232,892, filed Aug 10, 2016, issued as US 9,879,022
Continuation of 14/678,114, filed Apr 3, 2015, issued as US 9,458,168
Apr 3, 2015 + 20y = Apr 3, 2035
Notes (1)
- [TD_DOCS_TRUNCATED] Found 4 filed TD documents; parsing first 3 only
Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated
You have the date. Your AI can have the file.
Application 16/996,117 · US 11,702,424
PatentReply compiles the prosecution history behind US 11,702,424: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.
One new published application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Permanent link
www.patentreply.ai/tools/patent-expiration/US11702424Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.